# FDA 483 - Hoxworth Blood Center University of Cincinnati - September 04, 2019

Source: https://www.keypedia.com/records/483/hoxworth-blood-center-university-of-cincinnati/7258797f-d3cd-4d02-ba02-07dc300fab4e

> FDA 483 for Hoxworth Blood Center University of Cincinnati on September 04, 2019. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Hoxworth Blood Center University of Cincinnati
- Inspection Date: 2019-09-04
- Product Type: biologics
- Office Name: Cincinnati District Office
- Summary: An FDA inspection of Hoxworth Blood Center University of Cincinnati Medical Center identified one observation related to donor contact information. The firm failed to verify that donors could be contacted at their provided address for eight weeks post-donation, despite having a procedure to prompt for an address. This indicates a potential gap in ensuring donor traceability.

## Related Officers

- [Jennifer L. Sheehan](https://www.keypedia.com/people/jennifer-l-sheehan/a49c628d-6eba-4b52-bafc-70785b9ba75e)

Company: https://www.keypedia.com/companies/hoxworth-blood-center-university-of-cincinnati/df854a82-5d7e-42da-94a6-433fc7194477

Office: https://www.keypedia.com/offices/cincinnati-district-office/b67a0c35-82e3-4176-9039-988378f65c22
